MedTrace Logo

Immediate Pain Relieving Effects of Sinbaro-3 for Low Back Pain

NCT02196129 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-11-07

No results posted yet for this study

Summary

The purpose of this study is to investigate the immediate pain relieving effects of sinbaro-3 pharmaco-acupuncture in patients with low back pain admitted for inpatient care

Conditions

  • Low Back Pain With Radiculopathy
  • Low Back Pain Without Radiculopathy
  • Herniated Intervertebral Disc

Interventions

DRUG

Sinbaro-3

1cc administered to site of pain(ashi acupoints), once and once only before any other intervention/if pain in both low back and extermities, the site of most pain

DRUG

Hwangryun

1cc administered to site of pain(ashi acupoints), once and once only before any other intervention/if pain in both low back and extermities, the site of most pain

Sponsors & Collaborators

  • Jaseng Hospital of Korean Medicine

    lead OTHER

Principal Investigators

  • Joonshik Shin · Jaseng Hospital of Korean Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2014-10-31
Completion
2014-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02196129 on ClinicalTrials.gov